Connect with us

News

CU Buffs women fall in overtime at Oregon State

Published

on

Dolphins’ Brandon Jones to miss second straight game; Jaelan Phillips active vs. Giants

CORVALLIS, Ore. — One team made timely shots and one team didn’t.

That was the difference Monday, as the Colorado women’s basketball team fell at Oregon State, 69-66 in overtime at Gill Coliseum.

“That’s probably a super accurate statement because the boards were pretty even and we did some really good things defensively and such but yeah, they made shots when they needed to and we did not,” CU head coach JR Payne said after a disappointing defeat in the first Pac-12 road game of the season.

The 22nd-ranked Buffaloes (13-2, 2-2 Pac-12) lost their second in a row after a 13-0 start to the season, despite 18 points from Quay Miller and a double-double (13 points, 11 rebounds) from Mya Hollingshed.

Oregon State (8-4, 1-1) got a 3-pointer from Talia von Oelhoffen with 18 seconds to play in overtime to snap the 66-66 tie. CU had no timeouts remaining and raced down the court to try to tie the game, but Jaylyn Sherrod’s 3-point attempt was off the mark.

The Buffs, who led 61-56 with less than three minutes left in regulation, went 1 for 13 from the floor in the final eight minutes, including 0 for 7 in overtime.

“It was real disappointing,” said Frida Formann, who had 13 points for the Buffs. “We definitely felt like we shouldn’t be in an overtime situation and a last shot situation. We just need to be tougher and more composed and have better IQ in those moments, but we’re going to learn from it.”

CU out-rebounded Oregon State, the Pac-12’s No. 1 rebounding team, 38-36, but OSU snagged the final three boards. One of those came with about 20 seconds to play in overtime. After von Oelhoffen missed a jumper, Jelena Mitrovic got the rebound and kicked it out to Ellie Mack, who quickly flipped the ball to von Oelhoffen, who then drained the game-winning 3.

“If you force Talia to miss a shot and then you give up an O-board and give her another chance, she’s not gonna miss twice,” Payne said. “We actually did a pretty good job on the defensive glass against them because they’re very good on the glass, but those last one or two were crucial.”

CU was looking to rebound from a 60-52 loss to No. 2 Stanford on Friday and jumped to a 12-7 lead early. OSU led after each of the first three quarters, however.

Although neither team ever led by more than five, CU had to battle all afternoon to keep pace.

Formann had nine of her 13 points in the fourth quarter, including a 3-pointer that sparked a 7-0 run to give the Buffs a 61-56 lead.

OSU responded with back-to-back 3-pointers, however. Formann hit a layup and then drained 1 of 2 free throws with 12.4 seconds to go in regulation to give the Buffs a 64-62 lead, but Mack sent the game to overtime by hitting a jumper with 7.7 seconds to go.

After the game, the Buffs headed to Boulder after the short trip, but look to regroup before heading out to Arizona State on Friday.

“It’s the next-game mindset,” Payne said. “Just be the ultimate learning group and be able to take the good and the bad from every single game and be able to take what happened and didn’t happen and you just use it to get better moving forward.”

Notes

CU remained at No. 22 in the Associated Press Top 25 poll released on Monday. This is the first time since December of 2016 that CU has been ranked in consecutive weeks. … Tayanna Jones had one of her best games in her two seasons at CU, scoring 10 points, pulling down six rebounds and recording three steals. … Oregon State blocked 12 CU shots. It’s the second time in the past four games CU has had 12 shots blocked. Prior to that, it had not happened in nearly six years.

Fast break

What went right: The Buffs out-rebounded the Pac-12’s top rebounding team, 38-36, and played solid defense much of the day.

What went wrong: The offense struggled when the Buffs needed it most. The Buffs made 44% of their shots in the first 37 minutes, but went 1-for-13 (7.7%) in the last eight minutes.

Star of the game: Tayanna Jones. She didn’t lead the Buffs in scoring or rebounding, but was exceptional off the bench with 10 points, six rebounds and three steals. She also had the Buffs’ only blocked shot.

What’s next: The Buffs visit Arizona State on Friday at 5 p.m. MT.

Oregon State 69, No. 22 Colorado 66 (OT)

COLORADO (13-2, 2-2 Pac-12)

Sherrod 2-9 0-0 4, Formann 5-14 1-2 13, Finau 0-4 0-0 0, Hollingshed 5-14 2-2 13, Tuitele 1-2 2-2 5, Jones 5-7 0-0 10, Sadler 0-1 1-2 1, Miller 6-13 5-6 18, Wetta 0-1 2-2 2. Totals 24-65 13-16 66.

OREGON STATE (8-4, 1-1 Pac-12)

Corosdale 3-8 2-2 9, Kampschroeder 1-2 0-0 3, von Oelhoffen 6-13 1-1 17, Adams 2-6 1-3 5, Brown 1-2 4-4 6, Mannen 0-0 0-0 0, Marotte 3-7 0-0 6, Mitrovic 2-4 0-2 5, Mack 6-6 0-0 16, Codding 1-7 0-0 2. Totals 25-55 8-12 69.

Colorado                     13        12        19        20        2          –           66

Oregon State               14        13        20        17        5          –           69

3-point goals – Colorado 5-18 (Formann 2-7, Miller 1-5, Hollingshed 1-3, Tuitele 1-1, Sherrod 0-2), OSU 11-27 (von Oelhoffen 4-8, Mack 4-4, Corosdale 1-4, Kampschroeder 1-2, Mitrovic 1-2, Codding 0-4, Marotte 0-2, Brown 0-1). Rebounds – Colorado 38 (Hollingshed 11), OSU 36 (Mack 7). Assists – Colorado 8 (Wetta 4), OSU 16 (Adams 6). Steals – Colorado 11 (Jones, Miller 3), OSU 10 (Corosdale 3). Turnovers – Colorado 11, OSU 18. Total fouls – Colorado 14, OSU 15. Fouled out – None. A – 3,854.

News

Ravens sign versatile LB Vince Biegel, helping defensive depth and special teams

Published

on

Ravens sign versatile LB Vince Biegel, helping defensive depth and special teams

The Ravens signed linebacker Vince Biegel to a one-year deal Monday, adding a versatile veteran to a position with limited depth. Terms of the deal were not disclosed.

Injuries have limited Biegel, 28, to just five games over the past two seasons, but he’s played both inside linebacker and outside linebacker and contributed regularly on special teams over his four-year NFL career. He tried out during the team’s rookie minicamp earlier this month and has ties to first-year outside linebackers coach Rob Leonard, who overlapped with him in Miami.

After missing the Dolphins’ 2020 season with a torn Achilles tendon, the 6-foot-3, 246-pound Biegel opened last season on injured reserve before returning to action in late November. Over his five games with Miami, he had two tackles and played primarily on special teams.

Biegel’s best season came in 2019, when he had 2 1/2 sacks, seven tackles for loss and 59 tackles over 15 Dolphins games (10 starts). The Wisconsin product started his career with the Green Bay Packers, who drafted him in the fourth round in 2017. He was cut before the next season and signed with New Orleans in 2018, playing a reserve role and contributing on special teams for the Saints.

The Ravens, who lost inside linebacker and special teams stalwart Chris Board in free agency, didn’t draft an inside linebacker last month and are cross-training Malik Harrison at outside linebacker this offseason. Biegel could also see snaps this offseason at outside linebacker, where Tyus Bowser and rookie Odafe Oweh are recovering from torn Achilles tendons.

()

Continue Reading

News

Pedro Martinez joining Mets’ Old Timers’ Day

Published

on

Pedro Martinez joining Mets’ Old Timers’ Day

Mets Old Timers’ Day is quickly becoming the hottest ticket in town.

On Monday, the team announced that Pedro Martinez would join the festivities on Aug. 27 at Citi Field.

Martinez, a first ballot Hall of Famer, spent four seasons with the Mets, racking up a 3.88 ERA in 79 starts. He was an All-Star for the team in 2005, a year in which he led the major leagues with a 0.949 WHIP, and again represented the Mets at the Midsummer Classic in 2006.

Martinez joins other big names including Mike Piazza, Mookie Wilson, Robin Ventura, John Matlack, Cliff Floyd and Ron Swoboda as participants in the game, which is being held for the first time since 1994.

Martinez has been a staple of MLB Network for years now, and this summer he will make his first appearance in a Mets uniform since 2008.

The Mets take on the Rockies on Aug. 27, with the Old Timers’ Day shenanigans beginning earlier in the day.

()

Continue Reading

News

Abbott says agreement reached to reopen baby formula plant

Published

on

Abbott says agreement reached to reopen baby formula plant

By ZEKE MILLER and MATTHEW PERRONE

WASHINGTON (AP) — Infant formula maker Abbott says it’s reached an agreement with U.S. health officials to restart production at its largest domestic factory, a key step toward easing a nationwide shortage tied to the plant’s shutdown earlier this year.

Abbott did not immediately detail the terms of the agreement reached with the Food and Drug Administration, which has been investigating safety problems at the Sturgis, Michigan, facility. The consent decree is a binding legal agreement between the company and the federal government.

After production resumes, Abbott has said it will take at least eight weeks to begin shipping new product to stores.

The Biden administration has come under intense pressure over the last week to do more to ease the shortage of formula that has forced parents of infants to go to significant lengths to feed their children.

Abbott’s plant came under scrutiny earlier this year after four infants became sick with bacterial infections after consuming powdered formula from the Michigan factory. Two of the babies died.

In February, the company halted production and recalled several brands of formula. Those steps squeezed supplies that were already strained by supply chain disruptions and parents stockpiling during COVID-19.

THIS IS A BREAKING NEWS UPDATE. AP’s earlier story follows below.

WASHINGTON (AP) — Under fire from parents and politicians, President Joe Biden’s administration on Monday is expected to announce an agreement to reopen the largest domestic manufacturing plant of infant formula and to ease import rules to allow supplies in from overseas, amid a nationwide shortage spurred by the Michigan plant’s shutdown earlier this year over safety issues.

A consent decree between the producer, Abbott, and the Food and Drug Administration that would pave the way for reopening the plant is “forthcoming,” said Brian Deese, the director of the White House’s National Economic Council. He added the agency would also take steps Monday to allow more foreign imports into the U.S. to address the urgent supply constraints.

It comes as the Biden administration has come under intense pressure over the last week to do more to ease the shortage of formula that has forced parents of infants to go to significant lengths to feed their children.

Over the weekend, the White House offered formula manufacturers and retailers transportation and logistics support, and working with all major formula producers to boost production, including reaching out to their suppliers to encourage them to prioritize production and delivery of formula ingredients.

Deese said the administration “made clear to all of them that federal resources, including transportation and logistics resources, are available and on call and we are prepared to move assets in coordination with them as and when we identify need.”

The shortage stems from a February recall by Abbott, the nation’s largest formula maker, that shuttered the company’s Michigan plant and exacerbated ongoing supply chain disruptions among formula makers, leaving fewer options on stores shelves across much of the country. The shortage has led retailers like CVS and Target to limit how many containers customers can purchase per visit and forced some parents to swap and sell formula online.

On Monday, FDA Commissioner Robert Califf told ABC News’ “Good Morning America” that the federal agency is “working really closely with Abbott” to reopen the closed Michigan factory and he expects that “in a very short period of time we’re going to have an announcement about the path forward.”

Califf said an announcement is forthcoming about importing baby formula from abroad, noting that the key is making sure the instructions for the formula are in languages that mothers and caregivers can understand.

The FDA warned families against making their own baby formula because it has 30 distinct constituents that have to be in the right amount, otherwise the formula can possibly be dangerous to consume.

Abbott’s voluntary recall was triggered by four illnesses reported in babies who had consumed powdered formula from the Michigan plant. All four infants were hospitalized with a rare type of bacterial infection and two died.

Abbott is one of just four companies that produce roughly 90% of U.S. formula, so its shutdown squeezed already tight supplies.

After a six-week inspection, FDA investigators published a list of problems in March, including lax safety and sanitary standards and a history of bacterial contamination in several parts of the plant.

But Chicago-based Abbott has emphasized that its products have not been directly linked to the bacterial infections in children. Samples of the bacteria found at its plant did not match the strains collected from the babies by federal investigators. The company has repeatedly stated it is ready to resume manufacturing, pending an FDA decision.

The terms of the consent decree were not immediately clear, including what steps Abbott was taking to remediate issues raised by the FDA or how quickly production at the plant would be restarted.

Former FDA officials say fixing the type of problems uncovered at Abbott’s plant takes time, and infant formula facilities receive more scrutiny than other food facilities. Companies need to exhaustively clean the facility and equipment, retrain staff, repeatedly test and document there is no contamination.

Even if the facility reopens soon, the FDA will still face scrutiny for its handling of the issues at the plant.

FDA inspectors visited the factory in September for a routine inspection, around the time that the first bacterial infection was reported in an infant. Although inspectors uncovered several violations— including standing water and unsanitary conditions— the FDA did not shut down the plant or issue any formal warning.

Only after several more illnesses were reported did the FDA return to the plant in January, this time finding a history of bacterial contamination in several parts of the plant. Abbott then shut down the facility and recalled several powdered formulas in mid-February.

Congresswoman Rosa DeLauro reported last month that a whistleblower had contacted the FDA in October about unsafe conditions and practices at the plant, including falsifying plant records and failing to properly test formula for contamination.

She and other lawmakers are set to question FDA Commissioner Califf about that issue and others at a hearing scheduled for Thursday.

Continue Reading

Trending